期刊
BIOLOGICAL TRACE ELEMENT RESEARCH
卷 200, 期 5, 页码 2099-2112出版社
SPRINGERNATURE
DOI: 10.1007/s12011-021-02812-0
关键词
Nanocomposite; Starch; Copper nanoparticles; Antimicrobial activity; Anticancer activity
Polysaccharides-based nanocomposites have been used for biomedical applications in recent years, and a nanocomposite based on myco-synthesized copper nanoparticles and starch was prepared in this study. The nanocomposite showed outstanding antimicrobial, antioxidant, and anticancer activities, making it promising for various biomedical applications.
In recent years, polysaccharides-based nanocomposites have been used for biomedical applications. In the current study, a nanocomposite based on myco-synthesized copper nanoparticles (CuNPs) and starch was prepared. The prepared nanocomposite was fully characterized using UV-visible spectroscopy (UV-vis), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscope (SEM), energy-dispersive X-ray spectroscopy (EDX), mapping, transmission electron microscope (TEM), and dynamic light scattering (DLS). Results revealed that this nanocomposite is characterized by nano spherical shape ranged around 200 nm as well as doped with CuNPs with size about 9 nm. Antimicrobial, antioxidant, and anticancer activities of the prepared nanocomposite were evaluated. Results revealed that CuNPs-based nanocomposite exhibited outstanding antibacterial and antifungal activity toward Escherichia coli ATCC25922, Bacillus subtilis ATCC605, Candida albicans ATCC90028, Cryptococcus neoformance ATCC 14,116, Aspergillus niger RCMB 02,724, A. terreus RCMB 02,574, and A. fumigatus RCMB 02,568. Moreover, CuNPs-based nanocomposite has a strong antioxidant activity as compared to ascorbic acid, where IC50 was 18 mu g/mL. Cytotoxicity test of CuNPs-based nanocomposite revealed that this nanocomposite is safe in use, where IC50 was 185.1 mu g/mL. Furthermore, CuNPs-based nanocomposite exhibited potential anticancer activity against MCF7 cancerous cell line where IC50 was 62.8 mu g/mL which was better than CuNPs alone. In conclusion, the prepared CuNPs with starch-based nanocomposite is promising for different biomedical applications as antimicrobial, antioxidant, and anticancer activities.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据